{
  "ticker": "EYE",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02973845",
  "id": "02973845",
  "pages": 11,
  "price_sensitive": true,
  "date": "20250729",
  "time": "1145",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250729/pdf/06m83myw0sfh11.pdf",
  "summary": "### **Quarterly Report (Appendix 4C) Summary**  \n\n#### **Financial & Operational Highlights**  \n- **FY25 Revenue**: Record **A$29.2M** (US$18.8M), up **23% YoY** (constant currency).  \n- **Q4 Revenue**: **A$8.8M** (US$5.7M) \u2013 highest quarterly result in company history.  \n- **H2FY25 EBITDA**: Glaucoma segment achieved **positive EBITDA (US$65K)**; group EBITDA loss reduced by **US$2.1M** vs. H1.  \n- **Cash Position**: **A$5.1M** at 30 June 2025 (corrected from A$6.265M). **Cash outflow from operations**: **A$847K** (Q4), improving trend.  \n- **Funding Runway**: **6 quarters** based on current cash and operations.  \n\n#### **FY26 Guidance**  \n- **Revenue (ex-China)**: **US$21M\u2013US$24M** (A$32M\u2013A$37M).  \n- **EBITDA Target**: Breakeven in **H1FY26**.  \n\n#### **Regulatory & Strategic Updates**  \n- **USA Medicare Reimbursement**: Proposed 2026 rates (finalized Nov 2025) expected to remain favorable for iTrack\u2122 adoption.  \n- **China FDA Approval**: iTrack\u2122 Advance approval expected **late 2025**; sales of legacy product continue.  \n- **Market Growth**: Independent analysis projects **US MIGS market share** to rise from **2.4% to 3.4%** by June 2026.  \n- **Grant Award**: **A$488K** from Australian Government for quantum/biomedical eye disease detection tech.  \n\n#### **Pipeline Developments**  \n- **iTrack\u2122 Drug Delivery**: Potential application in ocular therapeutics; evaluation results expected **H1FY26**.  \n\nNo capital raising or material restructuring disclosed.",
  "usage": {
    "prompt_tokens": 5179,
    "completion_tokens": 423,
    "total_tokens": 5602,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-29T02:02:59.544453"
}